Advanced cancer diagnostics can provide increasingly sophisticated information about tumor biology, but developing the test is only part of the challenge. How do we make these technologies available to patients wherever they receive care?
In this episode of MedInsights Unleashed, Dr. Oliver F. Bathe, MD, MSc, FRCSC, FACS, Professor of Surgery and Oncology at the University of Calgary and Founder and CEO of Qualisure Diagnostics, discusses the challenges of centralized testing and the move toward more decentralized approaches. He explores RNA and transcriptomics, computational assays, and the potential role of AI in helping make advanced cancer diagnostics more reproducible, scalable and accessible to patients.
Qualisure Diagnostics Inc contact information:
Oliver F. Bathe, MD – CEO & Founder
3655 36th Street NW Calgary, Alberta T2L 1Y8
p: +1 403.614.7124
